Understanding China’s Absolute Ban on Used Medical Devices
China’s prohibition on importing used medical devices is not a gray area — it is a clear statutory ban. The 2014 revision of the Medical Device Supervision and Administration Regulation (医疗器械监督管理条例, yīliáo qìxiè jiāndū guǎnlǐ tiáolì) formally ended the legal import of second-hand medical equipment across all risk classes.
The rationale behind the ban is patient safety and quality control. Chinese regulators determined that used devices pose unacceptable risks due to unknown usage history, potential contamination, and inconsistent maintenance. This concern is particularly acute for implantable and life-supporting devices.
Three contextual numbers illustrate the strictness of this policy. First, 2014 — the year the ban took full effect, ending a period when limited used-device imports were permitted. Second, 0% — the allowance for used Class III (high-risk) devices, meaning zero units of any such equipment can clear customs. Third, 100% — the share of imported medical devices that must hold valid NMPA registration certificates, with used devices unable to meet this requirement de facto.
The ban applies regardless of a device’s age, condition, or certification in the country of origin. A CT scanner used for only six months in a US hospital is legally considered “used” and cannot be imported to China as a second-hand unit. The only potential path forward is refurbishment through the original manufacturer — but even then, the device must be treated as a newly manufactured product in regulatory terms.
The Narrow Exception for Refurbished Medical Devices
While used devices are banned outright, refurbished medical devices (翻新医疗设备, fānxīn yīliáo shèbèi) may qualify for import under specific conditions that Chinese regulators treat as distinct from “used” equipment. The key distinction: a refurbished device must be restored to original manufacturer specifications by the original equipment manufacturer (OEM) or an authorized facility.
Chinese regulations do not have a separate “refurbished” category in the NMPA registration system. Instead, a refurbished device must obtain the same registration certificate (医疗器械注册证, yīliáo qìxiè zhùcè zhèng) as a new device. This means the device must undergo the full technical review, clinical evaluation, and quality system audit required for any new product entering the Chinese market.
The practical implications are significant. The refurbishment process must include replacement of all wear components, full recalibration, software updates to current versions, and certification that the device meets the same performance standards as a new unit. The OEM must also provide documentation of the refurbishment process, including serial numbers, component replacement records, and quality control reports.
Four numbers frame this exception. First, 12-36 — the months typically required to obtain NMPA registration for a refurbished device, comparable to a new device timeline. Second, 100% — the performance standard required, meaning a refurbished device cannot meet a lower benchmark than a new equivalent. Third, 3 — the maximum number of NMPA device classes, with Class III being the most difficult for refurbished devices to navigate. Fourth, 1 — the only entity permitted to perform refurbishment for import purposes: the original manufacturer.
NMPA Registration Requirements for Refurbished Equipment
The NMPA registration process for refurbished medical devices follows the same pathway as for new devices, with additional documentation requirements. Exporters must submit a complete technical file, including product specifications, manufacturing protocols, clinical data, and quality management system certifications.
For refurbished devices, the application must also include:
- A declaration from the OEM confirming the device was refurbished to new-device specifications
- Complete service and repair records for the device’s previous life
- Component replacement documentation with traceable serial numbers
- Calibration certificates and performance test results
- A statement explaining why a new device was not used instead
The registration process involves three main stages. Stage one is pre-submission consultation with NMPA’s Center for Medical Device Evaluation (CMDE), where applicants receive guidance on required data. Stage two is formal submission and technical review, which can take 6-12 months for Class II devices and 12-24 months for Class III devices. Stage three is post-approval compliance, including factory inspections and ongoing reporting obligations.
The cost of registration for refurbished equipment is identical to new device registration. Application fees range from ¥10,000 to ¥100,000 depending on device class, with additional costs for clinical trials, testing laboratories, and regulatory consultants. Total costs for a Class III refurbished device registration often exceed ¥500,000 when all associated expenses are included.
One crucial constraint: the refurbished device must be manufactured in a facility that holds ISO 13485 certification and has passed NMPA quality system audits. This effectively limits the exception to major global OEMs with established China operations.
Comparing Import Routes: Used vs. Refurbished vs. New
The table below summarizes the key differences between importing used, refurbished, and new medical devices to China.
| Parameter | Used Device | Refurbished Device | New Device |
|---|---|---|---|
| Legality | Prohibited for all classes | Conditionally permitted (OEM only) | Permitted with NMPA registration |
| NMPA registration required | Not applicable (cannot register) | Full registration required | Full registration required |
| Registration timeline | N/A | 12-36 months | 12-24 months |
| Registration cost (Class III) | N/A | ¥500,000+ | ¥300,000-800,000 |
| Performance standard | Unknown / variable | Must equal new device | New device standard |
| Remanufacturer | None | OEM only | OEM only |
| Warranty expectation | None | Same as new device | Standard manufacturer warranty |
| Market acceptance | Zero | Low; hospitals prefer new | High |
| Cost savings vs. new | 50-70% (theoretical) | 10-20% | Baseline |
The data in this table reflects current NMPA regulatory practice as of 2024. Note that the cost savings for refurbished devices are often eroded by registration expenses, making the total landed cost comparable to a new device in many cases.
Strategic Options for Exporters of Used and Refurbished Devices
Exporters considering the Chinese market for used or refurbished medical devices have three strategic options, each with distinct trade-offs.
Option one: OEM-led refurbishment programs. If you represent an OEM, the refurbishment route is theoretically available but rarely practical. The cost and timeline of NMPA registration for refurbished equipment are similar to new devices, and Chinese hospitals strongly prefer new equipment. Only a small number of high-value capital equipment refurbishment programs — primarily for MRI systems and CT scanners from major manufacturers — have succeeded in China.
Option two: export of new devices only. The most straightforward strategy is to abandon used and refurbished device exports entirely and focus on new equipment. China’s medical device market is the second-largest globally, with double-digit annual growth. The additional cost of new equipment is offset by faster regulatory timelines, higher buyer confidence, and no legal ambiguity.
Option three: service contracts and spare parts. Rather than exporting entire used or refurbished devices, consider exporting service contracts, spare parts, and maintenance agreements for installed device bases. Chinese hospitals have large inventories of imported equipment and need certified spare parts and authorized maintenance. This approach avoids the used-device import ban while generating recurring revenue.
Each option requires different regulatory preparation. Option one demands full NMPA registration capability and OEM authorization. Option two requires standard NMPA registration but no special refurbishment documentation. Option three generally does not require device registration but may need component registration for certain spare parts.
Common Misconceptions and Compliance Pitfalls
Several misconceptions lead exporters to pursue nonviable strategies when attempting to send used or refurbished medical devices to China.
Misconception one: “Refurbished is the same as used and both are equally prohibited.” This is incorrect. Refurbished devices that meet NMPA standards and come from the OEM can qualify for registration. However, the distinction is narrow and requires substantial documentation.
Misconception two: “Third-party refurbishers can qualify for import.” This is false. Chinese regulations do not recognize refurbishment by third-party companies, regardless of their certification or expertise. Only the original manufacturer can perform refurbishment for import purposes.
Misconception three: “Low-risk devices have easier refurbishment rules.” Partially true but misleading. Class I devices may face fewer barriers, but the ban on used devices applies across all classes. Even a refurbished blood pressure monitor requires documentation of OEM refurbishment and registration.
Misconception four: “Used devices can enter as personal baggage or donations.” This is a dangerous misconception. Customs strictly enforces the used-device ban across all import channels, including donations, personal imports, and samples. Attempting to circumvent the ban can result in seizure, fines, and exclusion from future imports.
Misconception five: “Older devices have lower compliance standards.” Incorrect. NMPA standards are the same regardless of device age. A refurbished device from 2018 must meet the same performance and safety criteria as a newly manufactured device from 2024.
Conclusion and Decision Framework
The export of used medical devices to China is legally impossible under current regulations. Refurbished devices from OEMs face a narrow and costly path that offers marginal cost savings over new equipment. For most exporters, the practical recommendation is to focus on new device registration and market entry.
For OEMs considering refurbishment programs, the decision should be based on a realistic assessment of total costs, registration timelines, and market demand. The 10-20% cost savings of refurbished equipment are often consumed by regulatory expenses, leaving little commercial advantage.
Exporters without manufacturing operations in China should explore service contracts and spare parts as alternative routes to participate in the Chinese medical market without confronting the used-device prohibition.
- Assess your device class and risk profile. Determine whether your equipment is Class I, II, or III under NMPA classification. Class III devices face the highest barriers and lowest probability of success for refurbishment. Read our guide on NMPA medical device classification for detailed criteria.
- Verify OEM authorization for refurbishment. If you are not the original manufacturer, confirm whether the OEM is willing to perform or authorize refurbishment for Chinese import. Without OEM involvement, the refurbishment route is closed. Review our article on OEM authorization requirements for China medical device imports.
- Compare total cost of refurbished vs. new entry. Prepare a full cost analysis that includes registration fees, clinical trial costs, consultant fees, and timeline opportunity costs. In most cases, new device registration offers better return on investment. Explore our medical device registration cost estimator for detailed comparisons.
